Lymphadenectomy Clinical Trials

Clinical trials related to Lymphadenectomy Procedure

Lymph Node Metastasis and Tumor Deposit in the Short Gastric Mesentery Following Total Gastrectomy With D2 Lymphadenectomy Plus Complete Mesogastric Excision for Gastric Cancer: A Prospective Observational Study

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

This study aims to explore lymph node metastasis in the short gastric mesentery following total gastrectomy with D2 lymphadenectomy plus complete mesogastric excision, providing evidence-based medicine for standardizing lymph node dissection in gastric cancer.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 85
Healthy Volunteers: f
View:

• Aged older than 18 years and younger than 85 years

• Primary gastric adenocarcinoma confirmed by preoperative pathology result

• cT2-4aN0-3M0 at preoperative evaluation according to the American Joint 8 Committee on Cancer (AJCC) Cancer Staging Manual 8th Edition

• Patients who received total gastrectomy with D2 lymphadenectomy plus complete mesogastric excision

• American Society of Anesthesiologists (ASA) class I, II, or III

• Written informed consent

Locations
Other Locations
China
Department of Gastrointestinal Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine
RECRUITING
Hangzhou
Contact Information
Primary
Tao Wang, Ph.d
15002740874@163.com
+86-197-068-25286
Time Frame
Start Date: 2024-05-01
Estimated Completion Date: 2027-12-31
Participants
Target number of participants: 150
Treatments
Patients who received total gastrectomy with D2 lymphadenectomy plus complete mesogastric excision
No additional intervention is imposed on patients except normal clinical diagnosis and treatment.
Sponsors
Leads: Jichao Qin

This content was sourced from clinicaltrials.gov

Similar Clinical Trials